OncLive launches weekly quiz covering recent breast, lung and pancreatic cancer updates
OncLive released its May 8, 2026 weekly news quiz, inviting readers to test their knowledge of recent developments in breast, lung and pancreatic cancers.
The quiz highlights several recent oncology stories, such as the phase 3 VIKTORIA-1 trial (NCT05501886) of a gedatolisib-based regimen in PIK3CA-mutant, hormone-receptor-positive/HER2-negative advanced breast cancer, as well as coverage of MD Anderson research breakthroughs, the 14th annual class of Giants of Cancer Care inductees, and poll results on top ASCO 2026 abstracts for lung and breast cancer.
Additional items mentioned include a failed first-line study of danvatirsen plus pembrolizumab in metastatic head-and-neck squamous cell carcinoma and a CME video on HER2-positive biliary tract cancer, alongside promotional content.
This writeup was produced by pharmadog from original reporting by onclive.
Original headline: “OncLive Weekly News Quiz (5/8/2026): Test Your Knowledge on Key Breast, Lung, and Pancreatic Cancer Updates”
read at onclive ↗
comments(0)
5-min edit window · permanent after that